API Supply Contract with Gilead Sciences
유한양행
000100
Signal Score
Historical Avg Return (5d)
+0.15%
Data Coverage
100%n=723
Risk-adjusted indicator based on 723 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Contract Amount: 210.19B KRW (139.81M USD)
- • Percentage of Recent Revenue: 9.61%
- • Contract Period: May 19, 2026 - December 31, 2027
- • Recent Revenue (2025): 2.18T KRW
AI Analysis Summary
Yuhan Corporation announced a significant API supply contract with Gilead Sciences, valued at 210.19B KRW (139.81M USD). This contract represents 9.61% of the company's 2025 consolidated revenue of 2.18T KRW. The agreement spans from May 19, 2026, to December 31, 2027, with payment terms of NET +30 days. This long-term contract is expected to positively impact future revenue and profitability, signaling continued demand for Yuhan's pharmaceutical ingredients.
How This Event Is Evaluated
Strategic Contract Evaluation
Contract events are evaluated by measuring business scale, revenue relevance, counterparty quality, and execution visibility.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Contract size relative to company revenue
- Expected revenue impact
- Counterparty quality
- Contract duration and execution period
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.